drugset / Trial / NCT00589979
Efficacy and Safety of the Lidoderm Patch Applied to Patients With Osteoarthritis of the Knee
RandomizedCrossoverTriple-blindTreatment
Summary
Patients with knee pain due to Osteoarthritis (OA) experiencing sub-optimal pain relief from their current analgesic regimen will participate in a pilot clinical trial to evaluate the effectiveness and tolerability of the Lidoderm Patch compared with placebo in treating knee pain from OA.
Timeline
- Start
- 2007-03
- Primary completion
- 2008-06
- Completion
- 2008-10
Outcome
Missed primary endpoint
registry analysis (superiority or other test); Sequence: Lidoderm - Placebo - Placebo (LPP) vs Sequence: Placebo - Lidoderm - Lidoderm (PLL); p = 0.1006; Hazard Ratio (HR) 1.78 (95% CI 0.89 to 3.55) NCT00589979 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lidocaine | Other / unclassified | 5 % | Topical |